ABDXF.US Abingdon Health Plc

Healthcare Biotechnology USA Stocks
0.2205 USD
Close of Nov 13, 2026
0.0700 0.2090
Market cap
USD 55.7M
P/E
-
P/B
6.84x
ROE
-34.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is ABDXF.US undervalued?

Graham number

The Graham number of Abingdon Health Plc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Abingdon Health Plc fundamental analysis

No fundamental analysis for Abingdon Health Plc yet.

Abingdon Health Plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Abingdon Health Plc

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturing, Product Sales, and Regulatory segments. The company also engages in manufacturing of lateral flow devices; and provision of support in meeting compliance requirements in international IVD and medical device markets. Its diagnostic products include PCRD: N…

Full company profile